Skip to main content
Fig. 4 | Harm Reduction Journal

Fig. 4

From: Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach

Fig. 4

Cost-effectiveness acceptability curve with the probability of cost-effectiveness of NSP by willingness-to-pay thresholds from probabilistic sensitivity analysis with 1,000 iterations of the simulation. Note: The results in this figure were compiled using data from the © Government of Québec (Research file publication date: 2009–2019; Data use approval date: 20 September 2021)

Back to article page